or
forgot password
  • cancer clinical trials in oklahoma city, OK

  • Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    Combination Chemotherapy in Treating Children With Neuroblastoma
    Children's Hospital at Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Neuroblastoma
    Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Breast Cancer
    S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer
    Veterans Affairs Medical Center - Oklahoma City
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Older Patients With Non-Hodgkin's Lymphoma
    Veterans Affairs Medical Center - Oklahoma City

    Trial Locations
    Veterans Affairs Medical Center - Oklahoma City
    University of Oklahoma Health Sciences Center
    Lymphoma
    S9712: Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage III Non-small Cell Lung Cancer
    Veterans Affairs Medical Center - Oklahoma City
    Oklahoma City, Oklahoma 73104
    Lung Cancer
    Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer
    St. Anthony Hospital

    Trial Locations
    St. Anthony Hospital
    University of Oklahoma Health Sciences Center
    Breast Cancer, Metastatic Cancer, Pain, Prostate Cancer
    Fluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the Pancreas
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Pancreatic Cancer
    SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil
    Veterans Affairs Medical Center - Oklahoma City
    Oklahoma City, Oklahoma 73104
    Colorectal Cancer
    Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Sarcoma
    Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the Vulva
    Oklahoma University Cancer Institute
    Oklahoma City, Oklahoma 73104
    Vulvar Cancer
    S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Cervical Cancer
    Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Cervical Cancer
    Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer
    S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Lymphoma
    Combination Chemotherapy in Treating Women With Breast Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Breast Cancer
    506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Leukemia, Lymphoma
    S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Neuroendocrine Carcinoma of the Skin
    S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
    Veterans Affairs Medical Center - Oklahoma City
    Oklahoma City, Oklahoma 73104
    Lung Cancer
    Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
    Children's Hospital at Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Colorectal Cancer
    High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
    Cancer Care Associates - Mercy Campus
    Oklahoma City, Oklahoma 73120
    Melanoma (Skin)
    Hormone Therapy With Arzoxifene Hydrochloride in Treating Women With Recurrent, Advanced, or Metastatic Endometrial Cancer
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Endometrial Cancer
    Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Gestational Trophoblastic Tumor
    Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Endometrial Cancer
    S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Malignant Mesothelioma
    Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
    Oklahoma University Medical Center at University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73126
    Leukemia
    O6-benzylguanine and Carmustine in Treating Children With Refractory CNS Tumors
    University of Oklahoma Health Sciences Center
    Oklahoma City, Oklahoma 73104
    Brain and Central Nervous System Tumors
    S9911, Combination Chemotherapy Plus Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Lymphoma
    S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer
    Oklahoma Medical Research Foundation

    Trial Locations
    Oklahoma Medical Research Foundation
    Veterans Affairs Medical Center - Oklahoma City
    Bladder Cancer
    S9804: Vinorelbine in Treating Patients With Stage IV Melanoma
    Veterans Affairs Medical Center - Oklahoma City
    Oklahoma City, Oklahoma 73104
    Melanoma (Skin)
    Diagnostic Study of Patients With Aggressive Non-Hodgkin's Lymphoma
    Oklahoma University Medical Center
    Oklahoma City, Oklahoma 73104
    Lymphoma
    Paclitaxel Plus Carboplatin With or Without SCH-58500 in Treating Patients With Newly Diagnosed Stage III Ovarian or Stage III Primary Peritoneal Cancer
    G. Rainey Williams Pavilion
    Oklahoma City, Oklahoma 73190
    Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Zoledronate in Treating Patients With Solid Tumors That Have Spread to the Bone
    University of Oklahoma College of Medicine
    Oklahoma City, Oklahoma 73190
    Hypercalcemia of Malignancy, Lung Cancer, Metastatic Cancer, Pain, Unspecified Adult Solid Tumor, Protocol Specific
    Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women
    Oklahoma University Medical Center at University of Oklahoma Health Sciences Center

    Trial Locations
    Oklahoma University Medical Center at University of Oklahoma Health Sciences Center
    Frank C. Love Cancer Institute at St. Anthony Hospital
    Breast Cancer